Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

sevirumab

Known as: SDZ-MSL-109, protovir, SDZ MSL 109 
 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Monoclonal Antibodies

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Mechanism for neutralizing activity by the anti-CMV gH/gL monoclonal antibody MSL-109
Significance The CMV glycoprotein (g) entry complex gH/gL is a significant target of the human immune system, eliciting… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2014
2014
In vitro affinity maturation of a natural human antibody overcomes a barrier to in vivo affinity maturation
Antibodies isolated from human donors are increasingly being developed for anti-infective therapeutics. These antibodies undergo… Expand
2013
2013
Einfluss verschiedener Methoden zur Bestimmung der mittleren Sprechstimmlage
ZusammenfassungHintergrundIn dieser Studie wurden unterschiedliche Methoden zur Bestimmung der mittleren Sprechstimmlage (MSL… Expand
2011
2011
Human cytomegalovirus escapes a naturally occurring neutralizing antibody by incorporating it into assembling virions.
Human cytomegalovirus (CMV) is a common but difficult to treat infection of immunocompromised patients. MSL-109 is a human… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Highly Cited
2009
Highly Cited
2009
Marginal Space Learning for Efficient Detection of 2D/3D Anatomical Structures in Medical Images
Recently, marginal space learning (MSL) was proposed as a generic approach for automatic detection of 3D anatomical structures in… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
2006
2006
First observations of separated atmospheric nu(mu) and anti-nu(mu) events in the MINOS detector
The complete 5.4 kton MINOS far detector has been taking data since the beginning of August 2003 at a depth of 2070 meters water… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2004
2004
A phase II, double-masked, randomized, placebo-controlled evaluation of a human monoclonal anti-Cytomegalovirus antibody (MSL-109) in combination with standard therapy versus standard therapy alone…
ACTG 266 was designed as a randomized study to evaluate two doses of the human monoclonal antibody directed against CMV gH (MSL… Expand
2002
2002
HIV and cytomegalovirus viral load and clinical outcomes in AIDS and cytomegalovirus retinitis patients: Monoclonal Antibody Cytomegalovirus Retinitis Trial
ObjectiveTo determine the association of cytomegalovirus (CMV) viremia with mortality and CMV retinitis progression in newly… Expand
2002
2002
Neutrino oscillation parameters from MINOS, ICARUS and OPERA combined
We perform a detailed analysis of the capabilities of the MINOS, ICARUS and OPERA experiments to measure neutrino oscillation… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Highly Cited
2001
Highly Cited
2001
Randomized, placebo-controlled, double-blind study of a cytomegalovirus-specific monoclonal antibody (MSL-109) for prevention of cytomegalovirus infection after allogeneic hematopoietic stem cell…
MSL-109 is a monoclonal antibody specific to the cytomegalovirus (CMV) glycoprotein H with high neutralizing capacity. In a… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE